Skip to main content
Joao de Andrade, MD, Pulmonology, Nashville, TN, Vanderbilt University Medical Center

JoaoA Mde AndradeMD

Pulmonology Nashville, TN

Critical Care Medicine, Interstitial Lung Diseases, Pleural Disease

Professor of Medicine, Vanderbilt University Medical Center

Dr. de Andrade is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. de Andrade's full profile

Already have an account?

Education & Training

  • University of Alabama Medical Center
    University of Alabama Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1997 - 2000
  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemResidency, Internal Medicine, 1994 - 1997
  • Fed Univ Rio Grande do Sul- Sch Med
    Fed Univ Rio Grande do Sul- Sch MedClass of 1990

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2019 - 2023
  • AL State Medical License
    AL State Medical License 1997 - 2022
  • American Board of Internal Medicine Critical Care Medicine
  • American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • AOA Alpha Omega Alpha Honor Medical Society, 2018
  • Distinguished Chest Educator American College of Chest Physicians, 2017
  • Jack D. Fulmer Award for Excellence in Teaching UAB, Division of Pulmonary, Allergy, and Critical Care Medicine, 2010, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations


Journal Articles

  • Oxidative Modifications of Protein Tyrosyl Residues are Increased in Plasma of Human Subjects with Interstitial Lung Disease  
    Pennathur S, Vivekanandan-Giri A, Locy ML, Kulkarni T, Zhi D, Zeng L, Byun J, de Andrade J, Thannickal VJ, Am J Respir Crit Care Med, 1/17/2015
  • The Idiopathic Pulmonary Fibrosis Clinical Research Network: Diagnostic and Adjudication Processes  
    de Andrade J, Schwarz M, Collard HR, Gentry-Bumpass T, Colby T, Lynch D, Kaner R; IPFnet Investigators, Chest, 1/1/2015
  • Pleiotropic Effect of the Proton Pump Inhibitor Esomeprazole Leading to Suppression of Lung Inflammation and Fibrosis  
    Ghebremarian YT, Cooke JP, Gerhart W, Griego C, Brower J, Doyle-Eisele M, Moeller BC, Zhou Q, Ho L, de Andrade J, Raghu G, Peterson L, Rivera A, Rosen GD, J Transl Med, 1/1/2015
  • Join now to see all

Books/Book Chapters


  • Establishing a Standard of Care for Patients with Idiopathic Pulmonary Fibrosis - Concept of "bundle of Care".
    Kulkarni T, Willoughby J, Kim Y, Ramachandran R, Luckhardt T, de Andrade J., Am J Respir Crit Care Med, 1/1/2015
  • Next Generation Sequencing Does Not Support a Causative Role for Herpes Virus in IPF
    Lasky J, Yin Q, Flemington E, Zhu D, Kaminski N, de Andrade J, Pulmonary Fibrosis Summit, Washington DC, 1/1/2015
  • A Bundle of Care Improves Outcomes in Idiopathic Pulmonary Fibrosis
    Kulkarni T, Acosta Lara P, Willoughby J, Kim Y, Ramachandran R, Alexander CB, Luckhardt T, Thannickal VJ, de Andrade J, Pulmonary Fibrosis Summit, Washington DC, 1/1/2015
  • Join now to see all


  • Idiopathic Pulmonary Fibrosis 
  • Non-pharmacological management of Idiopathic Pulmonary Fibrosis 
    Montreal, QC, Canada - 1/1/2015
  • Clinical Aspects of Other Interstitial Lung Diseases (Non-granulomatous) 
  • Join now to see all

Other Languages

  • Portuguese, Spanish

Hospital Affiliations